These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32025430)

  • 21. Facial nerve palsy in Lyme disease: evaluation of clinical diagnostic criteria.
    Smouha EE; Coyle PK; Shukri S
    Am J Otol; 1997 Mar; 18(2):257-61. PubMed ID: 9093686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.
    Aucott JN; Soloski MJ; Rebman AW; Crowder LA; Lahey LJ; Wagner CA; Robinson WH; Bechtold KT
    Clin Vaccine Immunol; 2016 Sep; 23(9):757-66. PubMed ID: 27358211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-onset Lyme carditis with concurrent disseminated erythema migrans.
    Patel KP; Farjo PD; Juskowich JJ; Hama Amin A; Mills JD
    Am J Cardiovasc Dis; 2017; 7(2):53-56. PubMed ID: 28533930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lyme disease and facial paralysis in children].
    Tuerlinckx D; Bodart E
    Rev Med Liege; 2001 Feb; 56(2):93-6. PubMed ID: 11294055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study.
    Hirsch AG; Poulsen MN; Nordberg C; Moon KA; Rebman AW; Aucott JN; Heaney CD; Schwartz BS
    Front Med (Lausanne); 2020; 7():560018. PubMed ID: 33324657
    [No Abstract]   [Full Text] [Related]  

  • 26. Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2.
    Horowitz RI; Freeman PR
    Healthcare (Basel); 2018 Nov; 6(4):. PubMed ID: 30400667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice.
    Eliassen KE; Hjetland R; Reiso H; Lindbæk M; Tschudi-Madsen H
    Scand J Prim Health Care; 2017 Mar; 35(1):75-83. PubMed ID: 28277054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area.
    Nigrovic LE; Thompson AD; Fine AM; Kimia A
    Pediatrics; 2008 Nov; 122(5):e1080-5. PubMed ID: 18931349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations of Lyme disease.
    Steere AC; Bartenhagen NH; Craft JE; Hutchinson GJ; Newman JH; Pachner AR; Rahn DW; Sigal LH; Taylor E; Malawista SE
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):201-5. PubMed ID: 3554839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyme disease in children.
    Shapiro ED; Seltzer EG
    Semin Neurol; 1997 Mar; 17(1):39-44. PubMed ID: 9166958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with culture-confirmed Lyme disease.
    Nowakowski J; Nadelman RB; Sell R; McKenna D; Cavaliere LF; Holmgren D; Gaidici A; Wormser GP
    Am J Med; 2003 Aug; 115(2):91-6. PubMed ID: 12893393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated detection of erythema migrans and other confounding skin lesions via deep learning.
    Burlina PM; Joshi NJ; Ng E; Billings SD; Rebman AW; Aucott JN
    Comput Biol Med; 2019 Feb; 105():151-156. PubMed ID: 30654165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
    Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
    mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Borreliosis in children - clinical manifestation, diagnosis and treatment].
    Duszczyk E; Karney A; Kowalewska-Kantecka B; Gryglicka H
    Med Wieku Rozwoj; 2003; 7(1):49-56. PubMed ID: 13130169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lyme disease in Pediatrics: different faces, the same disease. Cases series].
    Suárez Castañón C; García González V; Díaz Díaz E; López Vilar P; Pérez Méndez C
    Arch Argent Pediatr; 2015 Jun; 113(3):e164-7. PubMed ID: 25996338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care costs, utilization and patterns of care following Lyme disease.
    Adrion ER; Aucott J; Lemke KW; Weiner JP
    PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.
    Horowitz RI; Freeman PR
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttreatment Lyme disease syndrome.
    Aucott JN
    Infect Dis Clin North Am; 2015 Jun; 29(2):309-23. PubMed ID: 25999226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study.
    Backman K; Skogman BH
    BMC Pediatr; 2018 Jun; 18(1):189. PubMed ID: 29890951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a foundation for a case definition of post-treatment Lyme disease syndrome.
    Aucott JN; Crowder LA; Kortte KB
    Int J Infect Dis; 2013 Jun; 17(6):e443-9. PubMed ID: 23462300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.